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Hypotonic stress responseThe quality of platelets decreases over storage time, shortening their shelf life and potentially worsening trans-
fusion outcomes. The changes in mitochondrial function associated with platelet storage are poorly deﬁned
and to address this we measured platelet bioenergetics in freshly isolated and stored platelets. We demonstrate
that the hypotonic stress test stimulates both glycolysis and oxidative phosphorylation and the stored platelets
showed a decreased recovery to this stress. We found no change in aggregability between the freshly isolated
and stored platelets. Bioenergetic parameters were changed including increased proton leak and decreased
basal respiration and this was reﬂected in a lower bioenergetic health index (BHI). Mitochondrial electron trans-
port, measured in permeabilized platelets, showed only minor changes which are unlikely to have a signiﬁcant
impact on platelet function. There were no changes in basal glycolysis between the fresh and stored platelets,
however, glycolytic rate was increased in stored platelets when mitochondrial ATP production was inhibited.
The increase in proton leak was attenuated by the addition of albumin, suggesting that free fatty acids could
play a role in increasing proton leak and decreasing mitochondrial function. In summary, platelet storage causes
a modest decrease in oxidative phosphorylation driven by an increase in mitochondrial proton leak, which con-
tributes to the decreased recovery to hypotonic stress.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Platelet transfusions are an important clinical treatment for patients
undergoing chemotherapy, radiation, after surgery or trauma, and for
patients with inherited platelet disorders such as Bernard–Soulier syn-
drome and idiopathic thrombocytopenic purpura [1,2]. Platelets from
healthy human volunteers which are collected and stored in the blood
bank undergo a progressive decline in function and quality during stor-
age, which is generally characterized as the platelet storage lesion [3].
Key features of the platelet storage lesion include change in morpholo-
gy, decreased aggregation, increased glycolytic rate, decreased plasma
pH, decreased mitochondrial function, increased expression of activa-
tion markers, and a decreased hypotonic stress response [4–8]. Suc-
cessful platelet transfusion requires an increment in platelet count ofdextrose; Asc, ascorbate; BHI,
tion rate; HSA, human serum
ethyl-p-Phenylenediamine; XF,
gy, University of Alabama at
.30,000–50,000/μl per unit transfused, accompanied by normal function
in primary hemostasis [9]. Due to the platelet storage lesion and the po-
tential for bacterial contamination, hospitals discard platelets past day
5 of collection, leading to shortages and economic loss [10]. In this man-
uscript, we will deﬁne the bioenergetic changes of stored platelets, and
the mechanisms underlying these changes.
The processes of platelet activation and aggregation require both
glycolysis and oxidative phosphorylation, raising the question whether
themetabolic impairments of the storage lesion impact on platelet func-
tion. It has been reported that ATP, ADP and AMP levels decrease during
storage suggesting a deﬁciency in glycolysis and/or oxidative phosphor-
ylation [11]. A number of studies have reported decrease in glucose
levels, and an increase in lactate, in the platelet storage bags, suggesting
an active glycolytic pathway and possible inhibition of mitochondrial
function [12–14]. Since this increase in glycolytic rate occurs despite
an increase in fatty acids, which we would expect could support mito-
chondrial function, it also suggests a possible mitochondrial defect.
Indeed, a decrease in mitochondrial membrane potential has been
reported over storage time, but studies regarding mitochondrial respi-
ratory activities are conﬂicting. Some reports have shown that the ca-
pacity to consume oxygen over 7 days of storage was not altered, as
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Other studies have demonstrated an almost complete loss of mitochon-
drial function. For example, one study reported a decrease of basal res-
piration of approximately 60% at day 8whereas others report an almost
complete loss of function at the second day which contrasts with other
reports that show essentially little or no change [8,16,17]. Typically,
these studies use very small sample sizes and varying protocols for
platelet storagewhich are different from those used in transfusionmed-
icine [8,16,18]. In addition, isolation of mitochondria from the platelets
to analyze complex activities may lead to damage to the organelle
which can be avoided by using cellular bioenergetic analysis [19].
These factors could partially explain the inconsistency of these data.
Since both glycolysis and oxidative phosphorylation play an important
role in platelet function [20,21] it is important to resolve these issues
so effective strategies can be developed to improve the performance
of stored platelets following transfusion.Fig. 1.Aggregation andhypotonic stress response of freshly isolated and storedplatelets. Platele
using thrombin (0.5 U/ml) and (B) hypotonic stress response using equal volume of water. (C)
plot of platelets exposed to different hypotonic stress levels (0–75%) from one healthy voluntee
(0.5 U/ml). HSR represented as change in transmittance after addition ofwater. Aggregation and
andwhiskers drawnat 1.5× interquartile range. Data expressed asmean±SEM.Aggregation—
sample. **p b 0.01, different from freshly isolated. %%p b 0.01, %p b 0.05, OCR different from 0%In order to better understand the metabolic and functional changes
during storage, 38 platelet concentrates, between ages day 6 and
9, were obtained from the blood bank, and their mitochondrial and gly-
colytic functions were measured using the Seahorse Extracellular ﬂux
analyzer, and compared to freshly isolated platelets from healthy do-
nors. We found that aggregation following thrombin stimulation was
not signiﬁcantly different in the stored platelets, but recovery after the
hypotonic stress response was impaired in the stored platelets. Addi-
tionally, stored platelets showed a decrease in basal, and ATP linked
OCR, and an increase in proton leak and reserve capacity. We also ob-
served that the changes in bioenergetics in the stored plateletswere pri-
marily due to an increase in proton leak which we ascribed to the
uncoupling effect of fatty acids. In support of this hypothesis, addition
of human serum albumin (HSA) to stored platelets attenuated the in-
crease in proton leak, suggesting that it could be used as a possible ad-
ditive to preserve mitochondrial function in stored platelets.ts from fresh blood or storage bagswere isolated, followedby evaluation of (A) aggregation
Change in light transmittance after hypotonic stress response assay and (D) OCR vs. ECAR
r donor. Extent of aggregation is expressed as change in light transmittance after thrombin
HSR data graphed as box plots with lower 25th percentile,median, upper 75th percentile,
12 freshly isolatedplatelets and22 stored platelets; HSR— 3–4 donors. n=3 replicates per
water. ##p b 0.01, ECAR different from 0% water.
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2.1. Isolation of platelets
Platelets were isolated from freshly drawn healthy human blood
and platelet concentrates obtained from the blood bank as previously
described [21,22]. In brief, the platelet rich plasma was centrifuged at
1500 g and washed with PBS containing PGI2 (1 μg/ml) before counting
platelet number by turbidimetry. Institutional Review Board approval
(Protocol #X110718014) was obtained from the University of Alabama
at Birmingham for the isolation and use of platelets in these experi-
ments. In the blood bank, there are a minimum of 3 × 1011 platelets
per bag in approximately 300 ml of plasma containing acid citrate
dextrose (ACD) [2]. As a result, there are more platelets per volume of
plasma in the storage bags (100 × 107/ml) than in the circulation
(150–400 × 106/ml).Fig. 2.Mitochondrial function of freshly isolated and stored platelets. Freshly isolated and store
test was performed by establishing basal OCR followed by sequential injection of 1 μg/ml oligom
stress test. Indices of mitochondrial function— (B) Basal, (C) ATP-linked (AL), (D) Proton leak (
(H) BHI [(AL × RC)/(PL × NM)] were calculated. The indices are represented in a box plot with
quartile range. n = 35 individual donors for the freshly isolated and n = 38 individual bags fo2.2. Aggregation and hypotonic stress response
Platelet aggregation was monitored by light transmittance at
405 nm after addition of thrombin (0.5 U/ml) [23]. Platelet hypotonic
stress response measurements were modiﬁed and performed as previ-
ously described [24]. Brieﬂy, 40 × 106 platelets/ml were suspended in
100 μl XF assay buffer and added to a 96-well microtiter plate. Next,
100 μl water was added as the hypotonic challenge, and change in
light transmission was measured at 405 nm. Immediately following
the hypotonic challenge platelets swell, and subsequently return to
their original shape and size.
2.3. Mitochondrial measurements
Cellular bioenergetics was performed on the Seahorse Extracellular
Flux (XF) analyzer as described previously [21,22]. In brief, 1 × 107d platelets (10 × 106/well) were plated on Cell-Tak coated plates and mitochondrial stress
ycin, 0.6 μMFCCP and 10 μMantimycin A. (A) Representative OCR traces ofmitochondrial
Pl), (E) Maximal (Max), (F) Reserve capacity (RC), (G) Non-mitochondrial (NM) OCR and
lower 25th percentile, median, upper 75th percentile, and whiskers drawn at 1.5 × inter-
r the stored. *p b 0.05, **p b0.01, different from freshly isolated.
Fig. 2 (continued).
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XF DMEM media (DMEM with 1 mM pyruvate, 5.5 mM D-glucose,
4 mM L-glutamine, pH 7.4). The mitochondrial stress test was per-
formed bymeasuring the basal oxygen consumption rate (OCR) follow-
ed by sequential injection of oligomycin (1 μg/ml), FCCP (0.6 μM) and
antimycin A (10 μM). Extracellular acidiﬁcation (ECAR) was simulta-
neously measured. The mitochondrial permeabilization assay was
modiﬁed and performed as previously described [25]. Brieﬂy, the plate-
lets were plated in MAS buffer (70 mM sucrose, 220 mM mannitol,
10mMKH2PO4, 5mMMgCl2, 2mMHEPES, 1mMEDTA, pH7.2). Tomea-
sure complex I and complex II respiratory activities, saponin (60 μg/ml),
pyruvate (5 mM), malate (2.5 mM), succinate (10 mM) and ADP
(10 mM) or FCCP (0.6 μM) were injected. Then rotenone (1 μM) was
injected to assess complex I linked respiration, followed by injection of
antimycin A to measure complex II linked respiration. In order to
measure state 3 and 4 respirations with complex IV substrates, sa-
ponin (60 μg/ml), N,N,N′,N′-Tetramethyl-p-Phenylenediamine (TMPD
0.5 mM), and ascorbate (2 mM) were injected followed by oligomycin
(1 μg/ml) then antimycin A (10 μM).
2.4. Statistical analysis
Freshly isolated platelets from 35 adult volunteers and stored plate-
lets from 38 bags ranging from day 6–9 of storagewere used for the ex-
periments presented here. Statistical signiﬁcancewas calculated using a
2 tailed student t-test, and p b 0.05 was considered signiﬁcant.
3. Results
3.1. Aggregation and hypotonic stress response of freshly isolated and
stored platelets
No signiﬁcant difference in the thrombin-dependent (0.5 U/ml)
aggregation of freshly isolated platelets or stored platelets was found
(Fig. 1A). The hypotonic stress response was used as an additional mea-
sure of platelet function, which is also an indicator of platelet survivalafter transfusion in vivo [26]. For this experiment, an equal volume
of water (100 μl) was added to a platelet suspension in XF-DMEM,
after which light transmittance was monitored. In both types of plate-
lets, the light transmittance rapidly decreased after the addition of
water, due to swelling of the platelets (Fig. 1B). In the freshly isolated
platelets, there was recovery, as evidenced by change in light transmit-
tance which gradually increased and returned to baseline levels. On the
other hand, in the stored platelets, the light transmittance continued to
decrease, suggesting that the platelets continued to swell and were un-
able to restore their former morphology (Fig. 1B and C).
In order to determine the impact of the hypotonic stress response
on bioenergetics, both basal OCR and ECARwere measured for different
levels of hypotonicity. For this assay, freshly isolated plateletswere sup-
plemented with increasing amounts of water (0–75%), 30 min prior to
themeasurement of basal OCR and ECAR. The data obtainedwas plotted
as oxygen consumption rate (OCR) vs. extracellular acidiﬁcation rate
(ECAR) energy diagram (Fig. 1D). Even at 10% hypotonic stress, there
was a signiﬁcant increase in both OCR and ECAR consistent with
increased energy demand. As the amount of water increased, OCR also
increased until it reached a plateau. However, with 75% water, the in-
crease in OCR was attenuated and not different from control platelets
(Fig. 1D). These data are consistentwith the activation of both glycolysis
and oxidative phosphorylation during the hypotonic stress test and sug-
gest that bioenergetics could be impaired in the stored platelets.
3.2. Cellular bioenergetics for freshly isolated and stored platelets
Next a mitochondrial stress test was performed on platelets by
ﬁrst, establishing a basal OCR, which was 10% lower in the stored
compared to the freshly isolated platelets (Fig. 2A and B). Next,
oligomycin (1 μg/ml)was injected to inhibit themitochondrial ATP syn-
thase, which resulted in the expected decrease in OCR. Oligomycin-
dependent decrease in OCR was greater in the freshly isolated platelets
compared to stored (Fig. 2A). Next FCCP (0.6 μM)was injected to uncou-
ple the mitochondria and elicit maximal cellular respiration. FCCP
increased maximal respiration to the same extent in both the freshly
Fig. 3.Mitochondrial respiration in freshly isolated and stored platelets. Freshly isolated
and stored platelets were plated on Cell-Tak coated plates in MAS buffer, and the perme-
abilization assaywas performed. First basal OCRwas established, then saponin (60 μg/ml),
pyruvate (5 mM), malate (2.5 mM) and ADP (1mM)were injected, followed by rotenone
(10 μM), then antimycin A (10 μM). (A) Complex I + Complex II-dependent respiration
and (C) Complex IV-dependent respiration were determined. Saponin (60 μg/ml), TMPD
(0.5mM), ascorbate (2mM), ADP (1mM)were injected followed by sequential injections
of oligomycin (1 μg/ml) and antimycin (10 μM) + azide (20 mM). Data expressed as
mean ± SEM, n = 3–5 individual donors for the freshly isolated and n = 3–7 individual
donors for the stored platelets. **p b 0.01, different from freshly isolated.
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(10 μM) was injected to inhibit all mitochondrial oxygen consumption
and measure non-mitochondrial OCR, which decreased OCR to the
same extent in both groups of platelets (Fig. 2A and G). The indices of
ATP-linked, proton leak, and reserve capacity were calculated from the
bioenergetic proﬁles. ATP-linked OCR, a measure of oxygen consump-
tion linked to ATP production, was calculated by subtracting the OCR
after oligomycin injection from the basal OCR. ATP-linked respiration
signiﬁcantly decreased by approximately 23% in the stored platelets
compared to the freshly isolated (Fig. 2C). A measure of oxygen con-
sumption not coupled to ATP production is proton leak, which was cal-
culated by subtracting the rate after antimycin A injection from the rate
after oligomycin injection. Proton leak in the stored platelets signiﬁcant-
ly increased by 190% compared to the freshly isolated platelets, consis-
tent with mitochondrial uncoupling increasing in the stored platelets
(Fig. 2D). Reserve capacity, which is ameasure of howmuch the platelet
can increase its ATP output in response to demand, was calculated by
subtracting basal OCR from the rate after FCCP addition. Reserve capac-
ity was signiﬁcantly higher in the stored platelets compared to the
freshly isolated platelets (Fig. 2F). Integrating these indices of mito-
chondrial function into one value, we have used the Bioenergetic Health
Index (BHI) calculated using the formula:
BHI ¼ ATP−Linked  Reserve Capacity
Proton Leak  Non−mitochondrial :
BHI was 52% lower in the stored platelets compared to the freshly
isolated platelets (Fig. 2H).
3.3. Mitochondrial respiration in freshly isolated and stored platelets
The decrease in basal and ATP-linked respiration could be due to a
decrease in the activities of the mitochondrial electron transport chain
complexes, hence complex I and II mediated respiration was deter-
mined by permeabilizing the plasma membrane and supplementing
the mitochondria with excess amounts of substrates and ADP. Saponin
was used to permeabilize the plasma membrane along with the addi-
tion of pyruvate, malate (complex I associated substrates), succinate
(complex II associated substrate) and ADP (Fig. 3A). This caused a stim-
ulation of complex I and II dependent respiration in both the freshly iso-
lated and stored platelets, but this increase was signiﬁcantly lower in
the stored platelets (Fig. 3A). Next, rotenone was injected to inhibit
complex I mediated respiration, which decreased OCR in both groups
of platelets (Fig. 3A). Finally, antimycin A was injected to inhibit all mi-
tochondrial respiration, which as expected decreased OCR in both fresh
and stored platelets (Fig. 3A). Complex I or pyruvate/malate contribu-
tion to respiration was calculated by subtracting the rate after rotenone
injection from the rate after saponin and substrate injection. These data
showed an approximately 27% decrease in complex I mediated respira-
tion in stored platelets compared to control (Fig. 3A). Complex II or suc-
cinate linked respiration was calculated by subtracting the rate after
antimycin A injection from the rate after rotenone injection, which
showed a 23% decrease in complex II mediated respiration in the stored
platelets (Fig. 3A).
Next, the activity of complex IVwas tested bypermeabilizing themi-
tochondria and providing Tetramethyl-p-Phenylenediamine (TMPD) as
an electron donor to cytochrome c, alongwith ADP to stimulate respira-
tion. Ascorbate (Asc) was added to reduce oxidized TMPD to regenerate
its electron donation potential. There was no difference in the TMPD/
Asc stimulated respiration between the freshly isolated and stored
platelets (Fig. 3B). Next oligomycin was added to inhibit ATP synthase,
followed by injection of antimycin A + azide. The TMPD/Asc +
oligomycin OCR was calculated by subtracting the rate after antimycin
A + azide from the rate after oligomycin injection. This value is a mea-
sure of proton leak or uncoupling, whichwas approximately 90% higherOCR in the stored platelets compared to the freshly isolated platelets
(Fig. 3B).
3.4. Extracellular acidiﬁcation in freshly isolated and stored platelets
ECAR was measured simultaneously as OCR in both freshly isolated
and stored platelets as described in Fig. 2A. We have previously
shown that over 90% of the ECAR can be ascribed to glycolysis in plate-
lets [21]. Basal ECAR was not signiﬁcantly different between either
group of platelets (Fig. 4A,B). Oligomycin sensitive ECARwas calculated
by subtracting the rate after oligomycin injection from basal ECAR.
Oligomycin sensitive ECARwas approximately 13% higher in the stored
compared to the freshly isolated platelets, consistent with a higher gly-
colytic capacity in stored platelets (Fig. 4A).
To further demonstrate the relationship between mitochondrial
function and glycolysis, an OCR vs ECAR plot was utilized. The plot
showed higher OCR in the freshly isolated platelets, and no change in
the basal level of glycolysis (Fig. 4C), indicating that at a resting state
there is a lower mitochondrial contribution to ATP generation in stored
platelets, but no apparent loss in glycolytic capacity.
3.5. Mechanism of increased proton leak in platelets
Previous literature has shown that free fatty acids have a mitochon-
drial uncoupling effect in hepatocytes, rat liver, heart and skeletal
muscle mitochondria, which can be attenuated by the addition of
albumin [27–32]. To investigate the mechanism of increased proton
leak in stored platelets, human serum albumin (HSA) was injected to
Fig. 4.Glycolytic function of freshly isolated and stored platelets. Freshly isolated and storedplateletswere plated onCell-Tak coated plates and basal ECARwas established followed by the
injection of 1 μg/ml oligomycin (A) Representative ECAR traces of fresh and stored platelets. Indices of glycolytic function— (B) Basal and (C) Oligomycin sensitive ECARwere calculated.
(D) Basal OCR vs Basal ECAR plot of both freshly isolated and stored platelets, plotted as a percentage of freshly isolated. The indices are represented in a box plot with lower 25th per-
centile, median, upper 75th percentile, and whiskers drawn at 1.5 × interquartile range. n = 35 individual donors for the freshly isolated and n = 38 individual donors for the stored.
*p b 0.05, **p b 0.01, different from freshly isolated.
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modiﬁed and performed as shown in Fig. 2A, with the addition of HSA
(150 μM) after oligomycin injection and followed for 32 min. In the
freshly isolated platelets, basal OCR was established, after which
oligomycin followed by HSA were injected which caused a small but
non-signiﬁcant decrease in OCR. Following HSA injection, FCCP and
antimycin A were injected sequentially (Fig. 5A). Since albumin can
bind FCCP, it was titrated to give a similar maximal response as the con-
trol group. A higher dose of FCCP (3.5 μM) was used in all experiments
with HSA injections. The proton leak remaining after HSA injection was
calculated by subtracting the rate after HSA injection from the rate after
antimycin injection, which showed no difference in proton leak before
and after HSA injection (Fig. 5B). Maximal, reserve capacity and non-
mitochondrial OCR were not changed after HSA injection compared to
the control. Similar experimentswere also performedwith stored plate-
lets. After the injection of HSA, there was a large decrease in OCR in theHSA treated group compared to the control (Fig. 5C). The proton leak
after HSA injection was approximately 80% lower compared to the con-
trol (Fig. 5D). There were no changes in maximal, reserve capacity or
non-mitochondrial observed after HSA treatment compared to the con-
trol platelets (Fig. 5D).
These data suggest that fatty acids are contributing to the proton
leak in the stored platelets. To conﬁrm this hypothesis, platelets were
pre-treated with either BSA alone or palmitate conjugated to BSA
(200 μM) prior to performing the bioenergetic assay as described in
(Fig. 5A). Addition of palmitate-BSA increased basal OCR, which we
have shown previously, and was ascribed to an increase in substrate
supply causing increased oxidative phosphorylation [21]. Importantly,
the oligomycin-sensitive OCR was lower in the palmitate-BSA treated
group compared to the BSA control (Fig. 6A). Next, excess HSA
(150 μM) not conjugated with fatty acid was injected, which decreased
the proton leak only in the palmitate-BSA group (Fig. 6A).
Fig. 5. Effect of HSA on freshly isolated and stored plateletmitochondrial function. Freshly isolated and stored platelets were plated on Cell-Tak coated plates and amodiﬁedmitochondrial
stress test was performedwithmeasurement of basal, followed by injection of oligomycin (1 μg/ml), HSA (150 μM), FCCP (0.6 μM for controls and 3.5 μM for HSA group) and antimycin A
(10 μM). Representative bioenergetic traces of (A) freshly isolated and (C) stored platelets. Indices of bioenergetics including proton leak HSA (rate after HSA injection — rate after
antimycin A injection) were calculated for (B) fresh and (D) stored platelets. Data expressed as mean ± SEM, n = 3 individual donors for the freshly isolated and stored platelets.
**p b 0.01, different from freshly isolated.
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in thepalmitate-BSA group (Fig. 6A). Finally, addition of antimycinAde-
creases OCR to the same level in both the palmitate-BSA and BSA group
(Fig. 6A). Calculation of proton leak revealed an approximately 90%increase in proton leak in the palmitate-BSA treated group, and a 75%
decrease in the proton leak when HSA was added, bringing both the
control and HSA treated groups to the same level of proton leak
(Fig. 6B). Reserve capacity was higher in the HSA treated platelets
Fig. 6. Palmitate increases proton leak which can be inhibited by HSA. Freshly isolated and stored platelets were plated on Cell-Tak coated plates and pre-treated with either BSA or pal-
mitate-BSA (200 μM). (A) Bioenergetic proﬁlewas establishedwith ﬁrst a basal rate, then sequential injection of oligomycin (1 μg/ml), HSA (150 μM), FCCP (0.6 μMfor controls and 3.5 μM
for HSA group) and antimycin A (10 μM). (B) Indices of bioenergetics including proton leak after HSA injection (rate after HAS injection— rate after antimycinA injection)were calculated.
Data expressed as mean ± SEM, from one representative donor, n = 3–5 replicates per sample. *p b 0.05, **p b 0.01, different from freshly isolated.
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that fatty acids contribute to uncoupling in stored platelets which can
be attenuated by the addition of albumin.
4. Discussion
Platelet transfusion therapy is an essential and lifesaving treatment
for trauma and other conditions causing thrombocytopenia [1,2]. How-
ever, the storage of donor platelets for transfusions is problematic be-
cause of the decline in platelet quality over storage time, collectively
known as the storage lesion [4–7,10]. The storage lesion combined
with risk of bacterial contamination due to the need to incubate the
platelet units at room temperature, leads to a short shelf-life of 5 days
for banked platelets [10]. The platelet storage lesion is associated with
metabolic changes which could affect the quality and function of the
platelets in vivo, post-transfusion [12,15–17]. The increase in glycolysis
during storage accelerates plasma acidiﬁcation, and the decrease in mi-
tochondrial oxidative phosphorylation could have important effects on
the ability of platelets to activate and aggregate [21,33–39]. Previous
studies on the metabolic characteristics of the storage lesion have de-
scribed different levels of mitochondrial dysfunction, and the focus of
this studywas to accurately deﬁne themetabolic changes. Here, we uti-
lized a non-invasive Extracellular Flux analysismethodology to simulta-
neously monitor both mitochondrial function and glycolysis in stored
platelets after day 5 of storage compared to freshly isolated platelets.
The functional ability of freshly isolated and stored platelets was
compared by measuring aggregation and hypotonic stress responses.
We found that in the stored platelets the variability in aggregation
was considerably greater than those which were freshly isolated sug-
gesting a greater severity in function among the stored samples butthis did not reach signiﬁcance. As reported previously the stored plate-
lets could not recover during the hypotonic stress and this test is ener-
getically demanding for the platelet (Fig. 1). In support of these data,
studies using glycolytic inhibitors, and the non-speciﬁc inhibitor of mi-
tochondrial oxidative phosphorylation, furosemide, reported a decrease
in recovery after swelling, suggesting that the hypotonic stress response
is an energetically demanding process [40,41]. This predicted increased
demand for glycolysis and oxidative phosphorylation is demonstrated
in Fig. 1D which shows an almost 3 fold stimulation of ECAR as the
severity of the hypotonic stress increases. Interestingly, it has been
shown that recovery after the hypotonic stress response is a positive in-
dicator of platelet survival and recovery in vivo.
Analysis of bioenergetics showed a decrease in basal and ATP-linked
OCR, and increase in proton leak and reserve capacity in the stored
platelets compared to those which were freshly isolated (Fig. 2). The
basal respiration represents the oxygen consumption by the mitochon-
dria required to provide theATP necessary for themetabolic demands of
the platelet. The fact that basal respiration is lower in the stored plate-
lets than in the control could be due to a decrease in ATP demand by
the platelet or partial inhibition of the mitochondrial ATP synthase.
Interestingly, the platelet mitochondrial ATP synthase has been report-
ed to be inhibited in patients with sickle cell disease [42]. Further, anal-
ysis of state 3 respiration with complex I, II substrates and ADP by
permeabilizing the plasmamembrane revealed a 22% decrease in respi-
ration in the stored platelets (Fig. 3A). Inmarked contrast to other stud-
ies that have shown no changes in mitochondrial respiration, or
complete loss ofmitochondrial function,we demonstrated amodest de-
crease in individual parameters of cellular platelet bioenergetics, associ-
ated with storage. In the intact platelet the substrates for oxidative
phosphorylation are supplied by the sum of the metabolic pathways
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this reason maximal respiration in the intact platelet can be limited by
the endogenous substrate supply and likely explains why the inhibition
ofmitochondrial electron transport at complex I and II does not result in
a decreasemaximal respiration. These data also suggest that suchminor
changes in the activity of themitochondrial electron transport chain are
unlikely to have a signiﬁcant impact on platelet function.
Importantly, the individual respiratory components from the mito-
chondrial stress test are interactive and contribute to the overall bioen-
ergetic health of the platelet population [43]. Integrating all the indices
ofmitochondrial function in theBHI equation, it is evident that the over-
all bioenergetic health of the stored platelets is signiﬁcantly lower than
the freshly isolated platelets suggesting that this parameter could be
used as a screen of platelet bioenergetic function (Fig. 2H). These data
would suggest that the stored platelet would bemore susceptible to ox-
idative stress [19]. Additionally, there were no differences in basal gly-
colysis, but upon inhibition of mitochondrial function, glycolytic rate
was signiﬁcantly enhanced in the stored compared to the freshly isolat-
ed platelet (Fig. 4). This data demonstrates that stored platelets have an
enhanced capacity to augment glycolysis when mitochondria ATP syn-
thesis is inhibited. Previous studies have shown an increase in lactate,
during storage [7]. The data shown in Fig. 4D shows no signiﬁcant
changes in basal ECAR which suggests that the accumulation of lactate
in the platelet bag is a consequence of normal accumulation during
basal metabolism.
Interestingly, the most striking change in bioenergetics observed
was an increase in proton leak in the stored platelets (Figs. 2D and 3B)
which was inhibited by albumin (Fig. 5A and B). Earlier studies have
shown that free fatty acids can act asmitochondrial uncouplers, and ad-
dition of albumin attenuates this effect. Notably, it has also been shown
that plasma free fatty acids increase during platelet storage [44]. In sup-
port of this concept, we show that addition of palmitate increases pro-
ton leak, which was decreased with the addition of albumin (Fig. 6).
Mitochondrial uncoupling has been described as an adaptation to cold
stress to increase thermogenesis, and free fatty acids can induce this
thermogenesis by its action on uncoupling proteins and adenine nucle-
otide translocator (ANT) [31,45–50]. In the blood bank, platelets are
stored at room temperature inducing a cold stress, which along with
the increase in plasma free fatty acid could contribute to thermogenesis
by uncoupling of the mitochondria.
In summary, we have shown an approximately 10% decrease in
basal mitochondrial respiration and a substantial increase in proton
leak or mitochondrial uncoupling in platelets after the end of the stor-
age period of 5 days. This increase in proton leak was attenuated by al-
bumin, indicating that free fatty acids could be causing the uncoupling
effect. These data suggest that albumin could be explored as a novel ad-
ditive for platelet storage, in order to halt the increase in proton leak and
increase platelet survival, recovery and function in the patient after
transfusion.
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